dyslipoproteinemia

[dis-lip″o-pro″tēn-e´me-ah]

the presence of abnormal concentrations of lipoproteins, or of abnormal lipoproteins, in the blood. See also hyperlipoproteinemia and hypolipoproteinemia.

References in periodicals archive ?

Kwiterovich Jr., "Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents," Atherosclerosis, vol.

Feasibility of Ideal Cardiovascular Health Evaluation in a Pediatric Clinic Setting

It features epidermal proliferation and is associated with diabetes mellitus, hypertension, hyperuricemia, and dyslipoproteinemia.[sup][1] Psoriasis has a major effect on the quality of life, without affecting the life span in general.

Homocysteine: A Potential Common Route for Cardiovascular Risk and DNA Methylation in Psoriasis

Drug therapy includes statins, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and metformin to target dyslipoproteinemia, hypertension, and dysglycaemia, respectively [12].

The Efficacy of Acupuncture on Anthropometric Measures and the Biochemical Markers for Metabolic Syndrome: A Randomized Controlled Pilot Study

After evaluating secondary causes of dyslipoproteinemia (eg, hypothyroidism, diabetes mellitus, kidney disease, medications), initial therapy consists of therapeutic lifestyle management and treatment of comorbid conditions identified.

Clinical utility of LDL particle number to optimize management of LDL-related cardiovascular risk

Overweight, dyslipoproteinemia, and heart rate variability measures.

Heart rate variability in nondiabetic dyslipidemic young Saudi adult offspring of type 2 diabetic patients

Lipids and dyslipoproteinemia. In: McPherson RA, Pincus MR, editors.

A woman with primary biliary cirrhosis and hyponatremia

Karpe et al., "The anti-diabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients," Diabetes Care, vol.

Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus.

Heart-ridden diabetes mellitus

Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults.

Dyslipidemia prevalence, treatment, control, and awareness in the Canadian health measures survey

This edition has new and updated coverage of the chemical basis for analyte assays and common interferences, lipids and dyslipoproteinemia, markers in the blood for cardiac injury evaluation and related stroke disorders, among other additions.

Henry's clinical diagnosis and management by laboratory methods, 22d ed. (online access included)

"Enhanced oxidative stress and dyslipoproteinemia have been proposed as significant factors contributing to the accelerated development of macrovascular complications in diabetes," Dr.